SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-16-437343
Filing Date
2016-01-26
Accepted
2016-01-26 06:16:54
Documents
2
Group Members
DAVID SCHNELL, M.D.PROSPECT MANAGEMENT CO. III, L.L.C.RUSSELL C. HIRSCH, M.D., PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d15947dsc13ga.htm SC 13G/A 75411
2 EX-99.1 d15947dex991.htm EX-99.1 4336
  Complete submission text file 0001193125-16-437343.txt   81357
Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301
Business Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301 818-587-4500
KYTHERA BIOPHARMACEUTICALS INC (Subject) CIK: 0001436304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87021 | Film No.: 161359928
SIC: 2834 Pharmaceutical Preparations